The Discounted Cash Flow (DCF) valuation of Cytokinetics Inc (CYTK) is (173.67) USD. With the latest stock price at 62.72 USD, the upside of Cytokinetics Inc based on DCF is -376.9%.
Based on the latest price of 62.72 USD and our DCF valuation, Cytokinetics Inc (CYTK) is a sell. selling CYTK stocks now will result in a potential gain of 376.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 9.2% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (608.77) - (105.96) | (173.67) |
| Upside | -1070.6% - -268.9% | -376.9% |